Loading clinical trials...
Loading clinical trials...
Datscan scintigraphy is a nuclear medicine examination allowing the diagnosis of neurodegenerative pathologies linked to damage to dopaminergic pathways, such as Parkinson's disease (essential for the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT05741853 · Primary Progressive Aphasia, Dementia, and more
NCT05516719 · Parkinson's, Parkinson Disease, and more
CHRU NANCY Brabois, nuclear medicine department
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions